Skip to content
InstaBriefs
Story timeline
1 updates

Deal Discussions

AstraZeneca is reportedly exploring a $400 billion merger with U.S. rival Bristol Myers Squibb, according to the Financial Times.

updates

  1. AstraZeneca Explores $400 Billion Merger With Bristol Myers Squibb

    AstraZeneca is reportedly exploring a $400 billion merger with U.S. rival Bristol Myers Squibb, according to the Financial Times.